MARKET

BLUE

BLUE

Bluebird Bio Inc
NASDAQ
4.965
+1.655
+50.00%
Opening 15:20 05/14 EDT
OPEN
4.970
PREV CLOSE
3.310
HIGH
4.990
LOW
4.950
VOLUME
8.89M
TURNOVER
--
52 WEEK HIGH
28.60
52 WEEK LOW
3.200
MARKET CAP
48.61M
P/E (TTM)
-0.1998
1D
5D
1M
3M
1Y
5Y
1D
BUZZ-U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment
Reuters · 1h ago
Bluebird Bio Shareholders Get New All-Cash Offer From Private Equity
Benzinga · 1h ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 2h ago
Bluebird Bio Shares Soar After Carlyle, SK Capital Offer Amended
Dow Jones · 5h ago
BLUEBIRD BIO SHARES GAIN 49.7%; CO AMENDS MERGER AGREEMENT WITH CARLYLE, SK CAPITAL PARTNERS
Reuters · 5h ago
Bluebird bio soars on amended deal with Carlyle, SK Capital
Seeking Alpha · 5h ago
BUZZ- bluebird bio soars on revised offer from Carlyle, SK Capital Partners
Reuters · 6h ago
Bluebird Bio Amends Merger Agreement with Carlyle
TipRanks · 6h ago
More
About BLUE
More
bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. It markets three gene therapies: ZYNTEGLO (betibeglogene autotemcel, also known as beti-cel), SKYSONA (elivaldogene autotemcel, also known as eli-cel), and LYFGENIA (lovotibeglogene autotemcel, also known as lovo-cel). ZYNTEGLO is the first gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions. SKYSONA is used to slow the progression of neurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD). LYFGENIA is used for the treatment of sickle cell disease in patients ages 12 and older who have a history of vaso-occlusive events (VOEs).
Recently
Symbol
Price
%Change

Webull offers bluebird bio Inc stock information, including NASDAQ: BLUE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLUE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BLUE stock methods without spending real money on the virtual paper trading platform.